Event
Beginning: 11/18/25
Location: Online
Shell stabilized, heavy gas-core nanobubbles (~300 nm diameter) have gained interest as a robust contrast agent for imaging and therapy using ultrasound. These particles are vastly smaller than current clinical contrast agents, allowing for superior responsiveness and high concentration across therapeutic ultrasound frequencies. Due to these unique features, nanobubbles are highly responsive to ultrasound at a broad range of clinically relevant imaging and therapeutic ultrasound frequencies and can be used in applications that may not be well suited for larger bubbles.
The localized nature of these nanobubbles provides key clinical opportunities (including cancer cells, and immune cells). Their targeted uptake allows for background-free, cell-specific imaging when paired with molecular targeting of cancer biomarkers. Crucially, this same localization enables the delivery of potent, precision therapeutic benefits—both as a standalone treatment and in combination with other therapies. We'll provide a comprehensive overview of the unique properties, advanced characterization methods, and emerging therapeutic applications of these lipid-shelled nanobubbles.
What You'll Learn:
- Learn about gas-core nanoparticle properties and benefits
- Become familiar with characterization methods for gas-core nanoparticles
- Gain knowledge in the applications of nanobubbles in ultrasound imaging and ultrasound-mediated drug delivery
Presented by Dr. Agata Exner - Director, Case Western Reserve University, Center for Imaging Research.
